An open-label, randomized, parallel-group, adaptive design with
blinded outcome adjudication trial conducted to compare the
efficacy and safety of milvexian and enoxaparin in patients
undergoing elective knee arthroplasty.
About the Podcast
We bring you clinical summaries and critiques of the most trending medical literature on the market